Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Antifungal resistance and susceptibility, Fungal Infections and Studies, Neutrophil, Myeloperoxidase and Oxidative Mechanisms, and Fungal Biology and Applications.
Tuning sterol extraction kinetics yields a renal-sparing polyene antifungal
Protective Efficacy of Anti-Hyr1p Monoclonal Antibody against Systemic Candidiasis Due to Multi-Drug-Resistant Candida auris
A bacterial endosymbiont of the fungus Rhizopus microsporus drives phagocyte evasion and opportunistic virulence
The Combination Treatment of Fosmanogepix and Liposomal Amphotericin B Is Superior to Monotherapy in Treating Experimental Invasive Mold Infections
Mucoricin is a ricin-like toxin that is critical for the pathogenesis of mucormycosis
Combination treatment of liposomal amphotericin B and isavuconazole is synergistic in treating experimental mucormycosis
GRP78 and Integrins Play Different Roles in Host Cell Invasion during Mucormycosis
Fosmanogepix (APX001) Is Effective in the Treatment of Pulmonary Murine Mucormycosis Due to Rhizopus arrhizus
Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis
Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosis
PCR-Based Approach Targeting Mucorales-Specific Gene Family for Diagnosis of Mucormycosis
An integrated genomic and transcriptomic survey of mucormycosis-causing fungi
Bicarbonate correction of ketoacidosis alters host-pathogen interactions and alleviates mucormycosis
Isavuconazole Therapy Protects Immunosuppressed Mice from Mucormycosis
CotH3 mediates fungal invasion of host cells during mucormycosis
NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response
Efficacy of Liposomal Amphotericin B and Posaconazole in Intratracheal Models of Murine Mucormycosis